RCSI research has found that venetoclax, a medication currently approved for leukaemia, has benefits for patients...

Testing for tumour DNA in the blood can successfully identify advanced bladder cancer patients who will...

A PSA blood test every five years is sufficient to screen low-risk men for prostate cancer,...

Review aims to implement a more personalised and multidisciplinary approach in treatment of menopause...

The Congressional Caucus heard how a unique partnership has significantly increased both the quality and...

Michelle, a 46-year-old female, underwent biopsy of a lesion in her left sided chest musculature in...

This year’s ISMO meeting heard presentations on a variety of high-quality cancer studies that have taken...

In this issue, highlights from the 2023 Gathering Around Cancer as well as national and international...

More people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs that...

Gathering Around Cancer, Croke Park Conference Centre, Dublin, 16-17 November 2023...

While some perceive peer review systems as “a soft touch”, the processes of the Organisation of...

Climate change will have an impact on the health system, including cancer care provision, the Gathering...